Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis C

  Free Subscription


09.09.2019

3 Am J Gastroenterol
2 Eur J Gastroenterol Hepatol
1 J Gastroenterol
1 J Infect Dis
1 J Virol
4 N Engl J Med
1 Scand J Gastroenterol
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. WIELAND A, Kohli R
    Non-Alcoholic Steatohepatitis as a Growing Indication for Liver Transplantation: The Evolving Gender and Ethnic Trends.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0373.
    PubMed     Text format     Abstract available

  2. ACHARYA C, Bajaj JS
    Current Management of Hepatic Encephalopathy.
    Am J Gastroenterol. 2018 Jul 13. pii: 10.1038/s41395-018-0179.
    PubMed     Text format     Abstract available

  3. NOUREDDIN M, Vipani A, Bresee C, Todo T, et al
    NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0088.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  4. MORALES-ARRAEZ D, Nieto Bujalance Y, Diaz-Flores F, de Vera A, et al
    Risk of liver fibrosis progression in patients with suboptimal diagnosis of hepatitis C virus infection.
    Eur J Gastroenterol Hepatol. 2019 Sep 3. doi: 10.1097/MEG.0000000000001534.
    PubMed     Text format     Abstract available

  5. CHUN HS, Kim BK, Park JY, Kim DY, et al
    Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2019 Sep 3. doi: 10.1097/MEG.0000000000001512.
    PubMed     Text format     Abstract available


    J Gastroenterol

  6. PUIGVEHI M, Londono MC, Torras X, Lorente S, et al
    Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients.
    J Gastroenterol. 2019 Sep 6. pii: 10.1007/s00535-019-01619.
    PubMed     Text format     Abstract available


    J Infect Dis

  7. RAGONNET-CRONIN M, Jackson C, Bradley-Stewart A, Aitken C, et al
    Recent and Rapid Transmission of HIV among People who Inject Drugs in Scotland Revealed through Phylogenetic Analysis.
    J Infect Dis. 2018 Mar 13. pii: 4931169. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  8. WANG H, Tai AW
    Nir2 is an effector of VAPs necessary for efficient HCV replication and PI(4)P enrichment at the viral replication organelle.
    J Virol. 2019 Sep 4. pii: JVI.00742-19. doi: 10.1128/JVI.00742.
    PubMed     Text format     Abstract available


    N Engl J Med

  9. WOOLLEY AE, Fanikos J, Baden LR
    Heart and Lung Transplants from HCV-Infected Donors. Reply.
    N Engl J Med. 2019;381:989.
    PubMed     Text format    

  10. NITTA D, Imamura T
    Heart and Lung Transplants from HCV-Infected Donors.
    N Engl J Med. 2019;381:988-989.
    PubMed     Text format    

  11. INDOLFI G, Azzari C, Resti M
    Heart and Lung Transplants from HCV-Infected Donors.
    N Engl J Med. 2019;381:988.
    PubMed     Text format    

  12. ELFEKI MA, Romero-Marrero C, Carey WD
    Heart and Lung Transplants from HCV-Infected Donors.
    N Engl J Med. 2019;381:987-988.
    PubMed     Text format    


    Scand J Gastroenterol

  13. SHRIDHAR GULATI R, Wimalanathan T, Norheim Andersen S, Isaksen K, et al
    The relationship between IFNL4 genotype and the rate of fibrosis in hepatitis C patients.
    Scand J Gastroenterol. 2019 Sep 3:1-4. doi: 10.1080/00365521.2019.1643403.
    PubMed     Text format     Abstract available


    Transplantation

  14. HUANG E
    Hepatitis C Infection in Kidney Donors: A Call to Re-examine its Relevance as a Predictor of Transplant Outcomes.
    Transplantation. 2019 Sep 3. doi: 10.1097/TP.0000000000002950.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: